#France #Surgical Intelligence #Qaelon Medical #Strasbourg #FluidAI Medical

Qaelon Medical and FluidAI Medical Collaboration: A New Era in Surgical Leak Detection

In a groundbreaking partnership, Qaelon Medical has teamed up with FluidAI Medical to transform the landscape of surgical leak detection. Their collaboration aims to innovate a continuous surgical data ecosystem that spans the entire surgical journey, including the operating room and postoperative recovery stages. This initiative specifically targets anastomotic leaks, which are a significant concern in gastrointestinal surgeries.

Understanding Anastomotic Leaks

Anastomotic leaks (AL) pose severe complications post-surgery, often leading to extended recovery times and increased health risks for patients. Statistically, the incidence of AL can reach up to 30% in specific demographics, with morbidity could reach as high as 35% in rectal anastomosis cases. The repercussions can be dire; AL can lead to longer hospital stays that range from 2.4 to 5.3 times longer than uncomplicated cases, and treatment costs can surmount $72,000 per patient, nearly three times the cost of standard recovery.

The challenge most medical professionals face is that anastomotic leaks are often detected only after a patient's clinical decline, complicating interventions and negatively affecting outcomes. To resolve this, both companies are collaborating to create a unified framework that connects real-time data captured during surgical procedures with postoperative patient care.

A Continuous Surgical Data Ecosystem

The operational synergy between Qaelon and FluidAI Medical seeks to address the critical gaps across the surgical journey. Qaelon is known for developing an innovative intraoperative leak detection platform, marking a significant evolution in how surgical leak detection is approached. This platform aims to digitize surgical leak detection, providing an objective physiological signal at the precise moment of anastomotic creation and verification, a phase previously reliant on subjective assessment.

With real-time data on closure integrity being documented into electronic health records (EHR), both companies aim to enhance decision-making during surgeries.

On the other side, FluidAI Medical brings to the table its established Recovery Intelligence and Surgical Excellence (RISE) Program. This program utilizes the Origin™ device, which is FDA-cleared and allows for continuous bedside monitoring of surgical drainage. The data collected feeds into Stream Care™, an AI platform that pinpoints high-risk complications, including anastomotic leaks, thus facilitating faster and more targeted interventions.

Vision for the Future

Both companies are keen on unifying data from devices, EHRs, and partner technologies to operationalize Enhanced Recovery After Surgery (ERAS) protocols on a larger scale. Liam Burns, the CEO of Qaelon, asserts that as surgical practices become increasingly relied upon data, the future will be driven by ecosystems built on objective physiological signals. They envision that through the collaboration with FluidAI, they can expedite the generation of clinical evidence and provide a more precise evaluation of surgical outcomes and economic value.

Dr. Eran Shlomovitz, Chief Medical Officer at Qaelon, states that the initiative not only represents significant progress in real-time assessment during surgery but also seeks to bridge one of the most pressing gaps in surgical care by extending monitoring into the postoperative phase.

Meanwhile, Youssef Helwa, CEO of FluidAI Medical, emphasizes the importance of connecting data across the perioperative journey. He notes that integrating previously untapped physiological data can provide clinicians with unprecedented context during recovery phases, which is crucial to improving patient outcomes.

A Collaborative Future

As the partnership evolves, Qaelon Medical and FluidAI Medical will collaborate with healthcare clinicians, research institutions, and industry partners to develop AI-driven analytics that will offer new insights on complication risks, healing patterns, and overall surgical quality. Their combined efforts will play a pivotal role in shaping the next standard of surgical care.

About the Companies

Qaelon Medical is pioneering surgical technology aiming to redefine leak detection methods to enhance intraoperative transparency. Conversely, FluidAI Medical focuses on using data-driven strategies to revolutionize the surgical care continuum, ensuring evidence-based practices lead to better patient outcomes. Both organizations are enthusiastic about their joint efforts and the future of surgical intelligence.